Skip to navigation Skip to content

Patient Support Programs

Download this unique, FREE tool and resource that provides important information about the diagnosis and management of multiple sclerosis for practicing clinicians. The App is a concise compilation of current, easy-to-reference, evidence-based information that you can access at no charge as an Apple and Droid "App".

App production made possible by Allergan, Bayer HealthCare, Novartis and Questcor Pharmaceuticals, Inc.

Download for iPhone

Download for Android


In this article

Alemtuzumab (Lemtrada)

Daclizumab (Zinbryta)

Zinbryta (daclizumab) was withdrawn from the worldwide market on March 2, 2018. Please see important information about the withdrawal in our Society News.

Dimethyl fumarate (Tecfidera)

Fingolimod (Gilenya)

Glatiramer acetate (Copaxone; Glatopa -- generic equivalent for 20 mg dose)

Interferon b-1a (Avonex)

Interferon b-1a (Rebif)

Interferon b-1b (Betaseron)

Interferon b-1b (Extavia)

Pegylated Interferon b-1a (Plegridy)

Mitoxantrone (Novantrone)

Natalizumab (Tysabri)

Ocrelizumab (Ocrevus)

  • Prescribing Information
  • Ocrevus Connects™
  • 1-844-OCREVUS (1-844-627-3887)

Teriflunomide (Aubagio)